GEMINI DIGITAL TWIN Trademark

Biomedical scientific research and development in the fields of biotechnology and pharmaceuticals, namely, analyzing multiple human biological and clinical data types simultaneously using causal artificial intelligence to assemble digital twin disease models that can be used to discover and validate human drug targets and biomarkers, and to simulate drug candidates and clinical trials in silico; Biomedical scientific research and development in the fields of biotechnology and pharmaceuticals; Computational modeling and simulation services for biological and biomedical research using causal artificial intelligence and multiomic human data; Drug target discovery and drug simulation services, including in silico clinical trial simulation and biomarker identification for patient stratification; Providing scientific research information in the field of drug discovery, pharmaceutical research and artificial intelligence-based computational disease modeling